Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IIMPACT: Solifenacin for UUI in Couples
NCT01559389Phase 4Completed
- Sponsor
- Loyola University Chicago
- Start
- Mar 2012
- Primary completion
- Jun 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, open-label trial of solifenacin in urge urinary incontinence (UUI) (2 arms), sponsored by Loyola University Chicago. Primary endpoint: Baseline Sexual Satisfaction Between Matched Female and Male Partners at 0 weeks. Started Mar 2012; status: completed.
02
Drugs
solifenacin
03
Conditions
urge urinary incontinence (UUI)
Beyond the preview
Go deeper on NCT01559389.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01559389.